Region: Europe | Target Audience: PCPs, Emergency Physicians, & Infusion/Triage Nurses
This enduring activity brings together leading experts across multiple disciplines to advance practical knowledge in recognizing, monitoring, and managing amyloid-related imaging abnormalities (ARIA) in patients with Alzheimer’s disease receiving anti-amyloid therapies (AATs). Through case-based discussion, evidence-driven updates, and multidisciplinary perspectives, the program focuses on improving confidence in ARIA identification, optimizing collaborative workflows across care settings, and strengthening patient-centered communication and shared decision-making to support safe and effective treatment.
RELEASED DATE: May 15, 2026
EXPIRATION DATE: May 15, 2027